Physician profile
Robert Foster
NPI 1679560528
$1,694.42
in general payments reported to CMS, 2019-2025
14 companies · $565 in 2025
The $565 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.10 · 2021: $24.56 · 2022: $382 · 2023: $202 · 2024: $469 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,207 · Honoraria: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,207.38 |
| Honoraria | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $644.16 | 2022-2025 | Vabysmo, Susvimo |
| Regeneron Healthcare Solutions, INC. | $361.56 | 2023-2025 | Eylea, Eylea Hd |
| Alimera Sciences, INC. | $178.48 | 2019-2024 | Yutiq, Iluvien |
| Astellas Pharma US INC | $115.25 | 2024-2025 | Izervay |
| Asd Specialty Healthcare, LLC | $89.70 | 2022 | |
| Abbvie INC. | $85.78 | 2024-2025 | |
| Apellis Pharmaceuticals, INC. | $59.13 | 2022-2025 | Syfovre |
| Ani Pharmaceuticals, INC. | $30.74 | 2025 | Iluvien |
| Lombart Brothers, INC. | $30.26 | 2019 | |
| Rxsight INC | $27.78 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $24.56 | 2021 | |
| Alcon Vision LLC | $23.87 | 2025 | Unity |
| Asahi Intecc USA, INC. | $23.15 | 2023 | Asahi Ptca Guide Wire |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.